This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Devlin N, Brooks R. EQ-5D and the EuroQol group: past, present, future. Appl Health Econ Health Policy. 2017;15(2):127–37.doi: 10.1007/s40258-017-0310-5.DevlinNBrooksREQ-5D and the EuroQol group: past, present, futureAppl Health Econ Health Policy20171521273710.1007/s40258-017-0310-5534308028194657Open DOISearch in Google Scholar
Richardson J, McKie J, Bariola E. Multiattribute utility instruments and their use. In: Culyer AJ, editor. Encyclopedia of health economics. San Diego: Elsevier, 2014:341–57.RichardsonJMcKieJBariolaEMultiattribute utility instruments and their useIn:CulyerAJeditor.Encyclopedia of health economicsSan DiegoElsevier20143415710.1016/B978-0-12-375678-7.00505-8Search in Google Scholar
Rules on inclusion of medicines on the list. Official Gazette 35/13. Accessed Apr 2020 at: https://www.uradni-list.si/glasilo-uradni-list-rs/vsebina/2013-01-1323?sop=2013-01-1323.Rules on inclusion of medicines on the listOfficial Gazette 35/13. Accessed Apr 2020 at: https://www.uradni-list.si/glasilo-uradni-list-rs/vsebina/2013-01-1323?sop=2013-01-1323.Search in Google Scholar
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36. doi: 10.1007/s11136-011-9903-x.HerdmanMGudexCLloydAJanssenMKindPParkinDDevelopment and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Qual Life Res20112017273610.1007/s11136-011-9903-x322080721479777Open DOISearch in Google Scholar
Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med. 1982;2005(60):1571–82. doi: 10.1016/j.socscimed.2004.08.034.MarraCAWoolcottJCKopecJAShojaniaKOfferRBrazierJEA comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritisSoc Sci Med198220056015718210.1016/j.socscimed.2004.08.03415652688Open DOISearch in Google Scholar
Sakthong P, Sonsa-Ardjit N, Sukarnjanaset P. Munpan W. Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases. Qual Life Res. 2015;24:3015–22. doi: 10.1007/s11136-015-1038-z.SakthongPSonsa-ArdjitNSukarnjanasetPMunpanWPsychometric properties of the EQ-5D-5L in Thai patients with chronic diseasesQual Life Res20152430152210.1007/s11136-015-1038-z26048348Open DOISearch in Google Scholar
Kim TH, Jo MW, Lee SI, Kim SH, Chung SM. Psychometric properties of the EQ-5D-5L in the general population of South Korea. Qual Life Res. 2013;22:2245–53. doi: 10.1007/s11136-012-0331-3.KimTHJoMWLeeSIKimSHChungSMPsychometric properties of the EQ-5D-5L in the general population of South KoreaQual Life Res20132222455310.1007/s11136-012-0331-323224560Open DOISearch in Google Scholar
Buchholz I, Janssen MF, Kohlmann T, Feng YS. A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. Pharmacoeconomics. 2018;36(6):645–61. doi: 10.1007/s40273-018-0642-5.BuchholzIJanssenMFKohlmannTFengYSA systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5DPharmacoeconomics20183666456110.1007/s40273-018-0642-5595404429572719Open DOISearch in Google Scholar
Rencz F, Lakatos PL, Gulácsi L, Brodszky V, Kürti Z, Lovas S, et al. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease. Qual Life Res. 2019;28(1):141–52. doi: 10.1007/s11136-018-2003-4. Epub 2018 Sep 17.RenczFLakatosPLGulácsiLBrodszkyVKürtiZLovasSValidity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s diseaseQual Life Res20192811415210.1007/s11136-018-2003-4Epub 2018 Sep 17.Open DOISearch in Google Scholar
Ogorevc M, Murovec N, Fernandez NB, Prevolnik Rupel V. Questioning the differences between general public vs. patient based preferences towards EQ-5D-5L defined hypothetical health states. Health Policy. 2019;123(2):166–72. doi: 10.1016/j.healthpol.2017.03.011.OgorevcMMurovecNFernandezNBPrevolnik RupelVQuestioning the differences between general public vs patient based preferences towards EQ-5D-5L defined hypothetical health statesHealth Policy201912321667210.1016/j.healthpol.2017.03.01128410808Open DOISearch in Google Scholar
Peeters Y, Stiggelbout AM. Health state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilities. Value Health. 2010;13:306–9. doi: 10.1111/j.1524-4733.2009.00610.x.PeetersYStiggelboutAMHealth state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilitiesValue Health201013306910.1111/j.1524-4733.2009.00610.x19744288Open DOISearch in Google Scholar
Devlin N, Shah K, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of Life: an EQ-5D-5L value set for England. Health Econ. 2017;1–16. doi: 10.1002/hec.3564.DevlinNShahKFengYMulhernBvan HoutBValuing health-related quality of Life: an EQ-5D-5L value set for EnglandHealth Econ201711610.1002/hec.3564668021428833869Open DOISearch in Google Scholar
Xie F, Pullenayegum E, Gaebel K, Bansback N, Bryan S, Ohinmaa A, et al. A time trade-off-derived value set of the EQ-5D-5L for Canada. Med Care. 2016;54(1):98–105. doi: 10.1097/MLR.0000000000000447.XieFPullenayegumEGaebelKBansbackNBryanSOhinmaaAA time trade-off-derived value set of the EQ-5D-5L for CanadaMed Care20165419810510.1097/MLR.0000000000000447467414026492214Open DOISearch in Google Scholar
Shiroiwa T, Ikeda S, Noto S, Igarashi A, Fukuda T, Saito S, et al. Comparison of value set based on DCE and/or TTO data: scoring for EQ-5D-5L health states in Japan. Value Health. 2016;19(5):648–54. doi: 10.1016/j.jval.2016.03.1834.ShiroiwaTIkedaSNotoSIgarashiAFukudaTSaitoSComparison of value set based on DCE and/or TTO data: scoring for EQ-5D-5L health states in JapanValue Health20161956485410.1016/j.jval.2016.03.183427565282Open DOISearch in Google Scholar
Kim SH, Ahn J, Ock M, Shin S, Park J, Luo N, et al. The EQ-5D-5L valuation study in Korea. Qual Life Res. 2016;25(7):1845–52. doi: 10.1007/s11136-015-1205-2.KimSHAhnJOckMShinSParkJLuoNThe EQ-5D-5L valuation study in KoreaQual Life Res201625718455210.1007/s11136-015-1205-226961008Open DOISearch in Google Scholar
Versteegh MM, Vermeulen KM, Evers SM, de Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19(4):343–52. doi: 10.1016/j.jval.2016.01.003.VersteeghMMVermeulenKMEversSMde WitGAPrengerRStolkEADutch tariff for the five-level version of EQ-5DValue Health20161943435210.1016/j.jval.2016.01.00327325326Open DOISearch in Google Scholar
Augustovski F, Rey-Ares L, Irazola V, Garay OU, Gianneo O, Fernandez G, et al. An EQ-5D-5L value set based on Uruguayan population preferences. Qual Life Res. 2016;25(2):323–33. Erratum in: Qual Life Res. 2016;25(2):335. doi: 10.1007/s11136-015-1086-4.AugustovskiFRey-AresLIrazolaVGarayOUGianneoOFernandezGAn EQ-5D-5L value set based on Uruguayan population preferencesQual Life Res201625232333Erratum in: Qual Life Res. 2016;25(2):33510.1007/s11136-015-1086-426242249Open DOISearch in Google Scholar
Mai VQ, Sun S, Minh HV, Luo N, Giang KB, Lindholm L, et al. An EQ-5D-5L value set for Vietnam. Qual Life Res. 2020. doi: 10.1007/s11136-020-02469-7. [AOP].MaiVQSunSMinhHVLuoNGiangKBLindholmLAn EQ-5D-5L value set for VietnamQual Life Res202010.1007/s11136-020-02469-7[AOP]Open DOISearch in Google Scholar
Rencz F, Brodszky V, Gulacsi L, Golicki D, Ruzsa G, Pickard AS, et al. Parallel valuation of the EQ-5D-3L and EQ-5D-5Lby time trade-off in Hungary. Value Health. 2020. [In Press].RenczFBrodszkyVGulacsiLGolickiDRuzsaGPickardASParallel valuation of the EQ-5D-3L and EQ-5D-5Lby time trade-off in HungaryValue Health2020[In Press].10.1016/j.jval.2020.03.01932940242Search in Google Scholar
Prevolnik Rupel V, Srakar A, Rand K. Valuation of EQ-5D-3L health states in Slovenia: VAS based and TTO based value sets. Zdr Varst. 2020;59(1):8–17. doi: 10.2478/sjph-2020-0002.Prevolnik RupelVSrakarARandKValuation of EQ-5D-3L health states in Slovenia: VAS based and TTO based value setsZdr Varst202059181710.2478/sjph-2020-0002747808432952698Open DOISearch in Google Scholar
van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15:708–15. doi: 10.1016/j.jval.2012.02.008.van HoutBJanssenMFFengYSKohlmannTBusschbachJGolickiDInterim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value setsValue Health2012157081510.1016/j.jval.2012.02.00822867780Open DOISearch in Google Scholar
Golicki D, Niewada M, van Hout B, Janssen MF, Pickard SA. Interim EQ-5D-5L value set for Poland: first crosswalk value set in Central and Eastern Europe. Value Health Reg Iss. 2014;4:19–23. doi: 10.1016/j.vhri.2014.06.001.GolickiDNiewadaMvan HoutBJanssenMFPickardSAInterim EQ-5D-5L value set for Poland: first crosswalk value set in Central and Eastern EuropeValue Health Reg Iss20144192310.1016/j.vhri.2014.06.001Open DOISearch in Google Scholar
EuroQol organization. EQ-5D-5L crosswalk value sets. Accessed 4 June 2020 at : https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/valuation-standard-value-sets/crosswalk-index-value-calculator/.EuroQol organizationEQ-5D-5L crosswalk value setsAccessed 4 June 2020 at : https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/valuation-standard-value-sets/crosswalk-index-value-calculator/.Search in Google Scholar
Brooks R. The EuroQol Group: EuroQol: the current state of play. Health Policy. 1996;37:53–72.doi: 10.1016/0168-8510(96)00822-6BrooksRThe EuroQol Group: EuroQol: the current state of playHealth Policy199637537210.1016/0168-8510(96)00822-6Open DOISearch in Google Scholar
Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095–108. doi: 10.1097/00005650-199711000-00002.DolanP.Modeling valuations for EuroQol health statesMed Care199735109510810.1097/00005650-199711000-000029366889Open DOISearch in Google Scholar
Zrubka Z, Beretzky Z, Hermann Z, Brodszky V, Gulácsi L, Rencz F, et al. A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases. Eur J Health Econ. 2019;20(Suppl 1):119–32. doi: 10.1007/s10198-019-01069-8.ZrubkaZBeretzkyZHermannZBrodszkyVGulácsiLRenczFA comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseasesEur J Health Econ201920Suppl 11193210.1007/s10198-019-01069-8654459531104218Open DOISearch in Google Scholar
R Core Team. R: a language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria. Accessed 4 June 2020 at : https://www.R-project.org/.R Core TeamR: a language and environment for statistical computingR foundation for statistical computingVienna, AustriaAccessed 4 June 2020 at : https://www.R-project.org/.Search in Google Scholar
Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer-Verlag, 2016.WickhamH.ggplot2: elegant graphics for data analysisNew YorkSpringer-Verlag201610.1007/978-3-319-24277-4Search in Google Scholar
Wickham H, François R, Henry L, Müller K. dplyr: a grammar of data manipulation. R package version 0.8.4. Accessed 4 June 2020 at : https://CRAN.R-project.org/package=dplyr.WickhamHFrançoisRHenryLMüllerKdplyr: a grammar of data manipulationR package version 0.8.4. Accessed 4 June 2020 at : https://CRAN.R-project.org/package=dplyr.Search in Google Scholar
Golicki D, Jakubczyk M, Niewada M, Wrona W, Busschbach JJV. Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe. Value Health. 2010;3(2):289–97. doi: 10.1111/j.1524-4733.2009.00596.x.GolickiDJakubczykMNiewadaMWronaWBusschbachJJVValuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern EuropeValue Health2010322899710.1111/j.1524-4733.2009.00596.x19744296Open DOISearch in Google Scholar
Golicki D, Jakubczyk M, Graczyk K, Niewada M. Valuation of EQ-5D-5L health states in Poland: the first EQ-VT-based study in Central and Eastern Europe. PharmacoEconomics. 2019;37:1165–76. doi: 10.1007/s40273-019-00811-7.GolickiDJakubczykMGraczykKNiewadaMValuation of EQ-5D-5L health states in Poland: the first EQ-VT-based study in Central and Eastern EuropePharmacoEconomics20193711657610.1007/s40273-019-00811-7683040231161586Open DOISearch in Google Scholar
